Updates are available Correction dated 2022-10-04
Click to view Correction: https://doi.org/10.1038/s41556-022-01017-4
-
Authors
Nakamura, Shuhei https://orcid.org/0000-0002-1488-8317
Shigeyama, Saki
Minami, Satoshi
Shima, Takayuki
Akayama, Shiori
Matsuda, Tomoki
Esposito, Alessandra
Napolitano, Gennaro
Kuma, Akiko
Namba-Hamano, Tomoko https://orcid.org/0000-0002-6049-7616
Nakamura, Jun
Yamamoto, Kenichi
Sasai, Miwa https://orcid.org/0000-0001-6440-3958
Tokumura, Ayaka
Miyamoto, Mika
Oe, Yukako
Fujita, Toshiharu
Terawaki, Seigo https://orcid.org/0000-0001-6019-1628
Takahashi, Atsushi
Hamasaki, Maho
Yamamoto, Masahiro
Okada, Yukinori https://orcid.org/0000-0002-0311-8472
Komatsu, Masaaki https://orcid.org/0000-0001-7672-7722
Nagai, Takeharu https://orcid.org/0000-0003-2650-9895
Takabatake, Yoshitsugu https://orcid.org/0000-0002-8912-2316
Xu, Haoxing https://orcid.org/0000-0003-3561-4654
Isaka, Yoshitaka
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Yoshimori, Tamotsu https://orcid.org/0000-0001-9787-3788
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development (17gm6110003h0001)
Japan Agency for Medical Research and Development (JP19gm5010001)
MEXT | JST | Core Research for Evolutional Science and Technology (JPMJCR17H6)
Human Frontier Science Program
- License Information
-
More Information
Article History
Received: 14 November 2019
Accepted: 25 August 2020
First Online: 28 September 2020
Change Date: 4 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41556-022-01017-4
Competing interests
: S.N. and T.Y. have applied for a patent for the assay related to this work (patent application no. 2020-63351). T.Y. is founder of AutoPhagyGO. A.B. is a co-founder of CASMA Therapeutics, Inc.
